GlassScriptPhysician profile
Rodney Ellis
NPI 1104986405
$10,560.62
in general payments reported to CMS, 2019-2025
45 companies · $1,561 in 2025
The $1,561 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,993 · 2020: $1,563 · 2021: $1,419 · 2022: $1,478 · 2023: $1,238 · 2024: $1,309 · 2025: $1,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,096 · Education: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,096.27 |
| Education | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,378.91 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,309.64 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $937.70 | 2019-2025 | Repatha, Otezla, Repatha |
| Vanda Pharmaceuticals INC. | $865.64 | 2022-2025 | Fanapt, Hetlioz |
| Lilly USA, LLC | $739.11 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Bayer Healthcare Pharmaceuticals INC. | $469.89 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $468.29 | 2019-2024 | |
| Abbvie INC. | $345.65 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $318.43 | 2019-2025 | Jardiance, Tradjenta |
| Abbott Laboratories | $315.81 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $292.64 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $235.17 | 2019-2020 | |
| Esperion Therapeutics, INC. | $195.30 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $171.14 | 2019-2022 | |
| Astellas Pharma US INC | $169.24 | 2023-2025 | Veozah |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.